Disruption of nongenomic testosterone signaling in a model of spinal and bulbar muscular atrophy.

Molecular Endocrinology
Mathilde SchindlerNorbert Bakalara

Abstract

As one of the nine hereditary neurodegenerative polyQ disorders, spinal and bulbar muscular atrophy (SBMA) results from a polyQ tract expansion in androgen receptor (AR). Although protein aggregates are the pathological hallmark of many neurodegenerative diseases, their direct role in the neurodegeneration is more and more questioned. To determine the early molecular mechanisms causing motor neuron degeneration in SBMA, we established an in vitro system based on the tetracycline-inducible expression of normal (AR20Q), the mutated, 51 glutamine-extended (AR51Q), or polyQ-deleted (AR0Q) AR in NSC34, a motor neuron-like cell line lacking endogenous AR. Although no intracellular aggregates were formed, the expression of the AR51Q leads to a loss of function characterized by reduced neurite outgrowth and to a toxic gain of function resulting in decreased cell viability. In this study, we show that both AR20Q and AR51Q are recruited to lipid rafts in response to testosterone stimulation. However, whereas testosterone induces the activation of the c-jun N-terminal kinase/c-jun pathway via membrane-associated AR20Q, it does not so in NSC34 expressing AR51Q. Phosphorylation of c-jun N-terminal kinase plays a crucial role in AR20Q-depend...Continue Reading

References

Jul 1, 1992·Developmental Dynamics : an Official Publication of the American Association of Anatomists·N R CashmanJ P Antel
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·E GiovannucciP W Kantoff
Mar 7, 1998·Journal of Neurochemistry·B P BrooksK H Fischbeck
Jan 5, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W P BentenF Wunderlich
Jun 9, 2000·Annual Review of Neuroscience·H Y Zoghbi, H T Orr
Aug 25, 2000·Human Molecular Genetics·A McCampbellK H Fischbeck
Jul 4, 2001·European Journal of Human Genetics : EJHG·A LundM L Savontaus
Aug 25, 2001·Journal of Neurochemistry·R ButlerJ M Gallo
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Aug 8, 2002·Human Molecular Genetics·Andrew P LiebermanKenneth H Fischbeck
Jul 26, 2003·The EMBO Journal·Simon MortonPhilip Cohen
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Charity FixWilliam H Walker
Jul 24, 2004·Nature Medicine·Christopher A Ross, Michelle A Poirier
Dec 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Anastassia HatzoglouElias Castanas
Dec 21, 2004·Journal of Neurochemistry·T U MarronA Poletti
Feb 22, 2005·Journal of Lipid Research·Jennifer L Macdonald, Linda J Pike
May 18, 2005·Neurobiology of Disease·Fengshan YuPak H Chan
Jul 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Fred SchaufeleMarc I Diamond
Oct 6, 2005·Nature Reviews. Genetics·Jennifer R Gatchel, Huda Y Zoghbi
Mar 4, 2006·Experimental Neurology·Masahisa KatsunoGen Sobue
Mar 24, 2006·The Journal of Biological Chemistry·Vera NovitskayaIlia V Baskakov

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.